X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7526) 7526
Book Review (1720) 1720
Publication (450) 450
Newsletter (205) 205
Newspaper Article (139) 139
Book Chapter (99) 99
Book / eBook (79) 79
Conference Proceeding (18) 18
Trade Publication Article (11) 11
Magazine Article (9) 9
Dissertation (5) 5
Data Set (2) 2
Government Document (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6039) 6039
index medicus (5979) 5979
hematology (3636) 3636
oncology (3424) 3424
male (3209) 3209
female (2976) 2976
adult (2754) 2754
middle aged (2725) 2725
chronic myeloid leukemia (2622) 2622
chronic myelogenous leukemia (2452) 2452
leukemia (2291) 2291
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (1808) 1808
aged (1757) 1757
chronic myeloid-leukemia (1725) 1725
imatinib mesylate (1490) 1490
cancer (1467) 1467
leukemia, myelogenous, chronic, bcr-abl positive - genetics (1398) 1398
imatinib (1330) 1330
adolescent (1290) 1290
antineoplastic agents - therapeutic use (1258) 1258
care and treatment (1159) 1159
treatment outcome (1158) 1158
research (1154) 1154
transplantation (1103) 1103
pyrimidines - therapeutic use (1047) 1047
benzamides (992) 992
prognosis (930) 930
leukemia, myelogenous, chronic, bcr-abl positive - pathology (924) 924
piperazines - therapeutic use (887) 887
cml (838) 838
fusion proteins, bcr-abl - genetics (836) 836
stem cells (805) 805
protein kinase inhibitors - therapeutic use (793) 793
genetic aspects (762) 762
bcr-abl (749) 749
hemic and lymphatic diseases (738) 738
therapy (722) 722
young adult (713) 713
acute lymphoblastic-leukemia (692) 692
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (692) 692
analysis (683) 683
medicine & public health (671) 671
leukemia, myelogenous, chronic, bcr-abl positive - therapy (670) 670
immunology (663) 663
health aspects (661) 661
child (654) 654
hematology, oncology and palliative medicine (634) 634
mutation (634) 634
dasatinib (630) 630
risk factors (623) 623
aged, 80 and over (622) 622
bone marrow (619) 619
transplantation, homologous (590) 590
diagnosis (585) 585
philadelphia chromosome (576) 576
bone-marrow-transplantation (563) 563
retrospective studies (561) 561
hematopoietic stem cells (538) 538
acute myeloid-leukemia (528) 528
chronic-phase (527) 527
tyrosine (526) 526
tyrosine kinase inhibitors (524) 524
drug therapy (516) 516
chemotherapy (484) 484
survival (475) 475
patients (474) 474
animals (470) 470
follow-up studies (450) 450
abridged index medicus (448) 448
interferon-alpha (442) 442
antineoplastic agents (439) 439
philadelphia-chromosome (436) 436
nilotinib (430) 430
follow-up (426) 426
leukemia, myelogenous, chronic, bcr-abl positive - mortality (416) 416
survival analysis (416) 416
stem-cell transplantation (413) 413
tyrosine kinase inhibitor (413) 413
antimitotic agents (408) 408
blast crisis (405) 405
bone marrow transplantation (402) 402
hematopoietic stem cell transplantation (399) 399
disease-free survival (379) 379
recurrence (374) 374
survival rate (370) 370
child, preschool (368) 368
karyotyping (368) 368
protein-tyrosine kinases - antagonists & inhibitors (368) 368
oncology, experimental (363) 363
kinases (360) 360
genetics & heredity (350) 350
cells (349) 349
myeloid leukemia (348) 348
antineoplastic agents - adverse effects (346) 346
pyrimidines - administration & dosage (337) 337
development and progression (333) 333
time factors (333) 333
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (331) 331
remission induction (329) 329
pyrimidines - adverse effects (326) 326
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (60) 60
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7923) 7923
Chinese (26) 26
Japanese (25) 25
German (20) 20
Spanish (18) 18
Russian (17) 17
French (7) 7
Portuguese (7) 7
Polish (5) 5
Czech (3) 3
Slovenian (3) 3
Korean (2) 2
Hungarian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 02/2012, Volume 119, Issue 5, pp. 1123 - 1129
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2015, Volume 168, Issue 1, pp. 69 - 81
Bosutinib is an oral, dual SRC / ABL 1 tyrosine kinase inhibitor for resistant/intolerant chronic myeloid leukaemia ( CML ). We assessed the efficacy and... 
BCR‐ABL1 | CML | tyrosine kinase inhibitor | bosutinib | chronic myeloid leukaemia | Chronic myeloid leukaemia | Tyrosine kinase inhibitor | Bosutinib | BCR-ABL1 | CHRONIC MYELOGENOUS LEUKEMIA | CYTOGENETIC RESPONSES | MOLECULAR RESPONSES | DASATINIB | NILOTINIB | RESISTANT | INTERFERON-ALPHA | IN-VITRO | PATIENTS RECEIVING IMATINIB | INHIBITOR | HEMATOLOGY | Piperazines - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Quinolines - administration & dosage | Nitriles - administration & dosage | Benzamides - administration & dosage | Benzamides - therapeutic use | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Odds Ratio | Benzamides - adverse effects | Aniline Compounds - administration & dosage | Pyrimidines - administration & dosage | Leukemia, Myeloid, Chronic-Phase - drug therapy | Treatment Outcome | Piperazines - therapeutic use | Imatinib Mesylate | Piperazines - adverse effects | Leukemia, Myeloid, Chronic-Phase - diagnosis | Leukemia, Myeloid, Chronic-Phase - mortality | Protein Kinase Inhibitors - administration & dosage | Fusion Proteins, bcr-abl - genetics | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Quinolines - therapeutic use | Aniline Compounds - therapeutic use | Mutation | Aniline Compounds - adverse effects | Nitriles - adverse effects | Quinolines - adverse effects | Nitriles - therapeutic use | Index Medicus | Haematological Malignancy
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2017, Volume 92, Issue 11, pp. 1214 - 1223
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2009, Volume 27, Issue 28, pp. 4754 - 4759
Journal Article
Cancer, ISSN 0008-543X, 01/2016, Volume 122, Issue 2, pp. 238 - 248
Journal Article
Blood, ISSN 0006-4971, 05/2012, Volume 119, Issue 19, pp. 4524 - 4526
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, pp. e0181366 - e0181366
Journal Article
Journal Article